BackgroundCheck.run
Search For

Ellen Marie Berg, 6021310 Thimbleweed Ct, Ashburn, VA 20147

Known as:
Ellen M Berg Ellen Mberg
Related to:
Betty L Waunch 89 Young S Kim

Ellen Berg Phones & Addresses

21310 Thimbleweed Ct, Ashburn, VA 20147    703-7236646   

3004 Columbus St, Arlington, VA 22206    703-9331123   

Falls Church, VA   

26526 Princeton Ave, Kent, WA 98032    253-8543963   

Federal Way, WA   

Kirkland, WA   

Pullman, WA   

Get Report
Control this profile

Mentions for Ellen Marie Berg

Ellen Berg resumes & CV records

Resumes

Ellen Berg Photo 46

Ellen Berg

Location:
United States
Ellen Berg Photo 47

Ellen Berg

Location:
United States
Ellen Berg Photo 48

Controller At Darcars Of New Carrollton

Position:
controller at darcars of new carrollton
Location:
Washington D.C. Metro Area
Industry:
Automotive
Work:
darcars of new carrollton
controller
Ellen Berg Photo 49

Ellen Berg

Location:
United States
Ellen Berg Photo 50

Ellen Berg

Location:
United States

Publications & IP owners

Us Patents

Leukocyte Homing Modulation

US Patent:
6387884, May 14, 2002
Filed:
Nov 9, 1994
Appl. No.:
08/336417
Inventors:
John L. Magnani - Gaithersburg MD, 20879
Eugene C. Butcher - Portola Valley CA
Ellen L. Berg - Fremont CA
Assignee:
Stanford University - Palo Alto CA
John L. Magnani - Rockville MD
International Classification:
A61K 3170
US Classification:
514 25, 514 8, 514 23, 514 53, 514 54, 514 61, 514 62, 530395, 536 111, 536 41, 536 172, 536 187
Abstract:
Novel methods and compositions are provided for modulating homing of leukocytes, particularly lymphocytes, where the compounds are cross-reactive with Neu5Ac2-3Gal1-X[Fuc1-y]GlcNAc, where one of x and y is three and the other is four. These compounds may be administered to a host associated with inflammation, to avoid the deleterious effects of leukocyte infiltration.

Methods And Compositions For Endothelial Binding

US Patent:
6391857, May 21, 2002
Filed:
Nov 9, 1994
Appl. No.:
08/336466
Inventors:
John L. Magnani - Rockville MD, 20853
Eugene C. Butcher - Portolla Valley CA
Ellen L. Berg - Fremont CA
Assignee:
Stanford University - Palo Alto CA
John L. Magnani - Frederick MD
International Classification:
A61K 3170
US Classification:
514 25, 514 8, 514 53, 514 54, 514 61, 514 62, 536 111, 536 41, 536 55, 536 551, 536 552, 530387, 530395, 530807, 4241841
Abstract:
Novel methods and compositions are provided for modulating homing of leukocytes, particularly lympho-cytes, where the compounds are cross-reactive with Neu5Ac2-3Gal1-X[Fuc1-y]GlcNAc, where one of x and y is three and the other is four. These compounds may be administered to a host associated with inflammation, to avoid the deleterious effects of leukocyte infiltration and for directing molecules to such sites.

Methods And Compositions For The Inhibition Of Cancer Metastasis Mediated By Endothelial Adhesion Molecules

US Patent:
6465434, Oct 15, 2002
Filed:
Nov 23, 1999
Appl. No.:
09/447532
Inventors:
John L. Magnani - Frederick MD, 21702
Eugene C. Butcher - Portola Valley CA
Ellen L. Berg - Palo Alto CA
Assignee:
Stanford University - Palo Alto CA
John L. Magnani - Rockville MD
International Classification:
A01N 4304
US Classification:
514 23, 514 53, 514 54, 514 61
Abstract:
Methods and compositions are disclosed for the inhibition of cancer metastases mediated by endothelial adhesion molecules. The present invention discloses that sialyl Le and di-sialyl Le , which are expressed at the surface of cancer cells, function as a binding partner for LEC-CAMs, such as ELAM-1, which are expressed at the surface of endothelial cells. The present invention also discloses that LEC-CAMs, such as ELAM-1, involved in cancer metastasis share a carbohydrate domain common to both sialyl Le and sialyl Le. Antibodies, saccharides, glycoconjugates, enzyme inhibitors and other compounds may be used in the methods of the present invention to inhibit the binding of malignant cells to endothelial cells for a variety of purposes in vivo and in vitro.

Methods And Compositions For The Inhibition Of Cancer Metastasis Mediated By Endothelial Adhesion Molecules

US Patent:
2003013, Jul 17, 2003
Filed:
Oct 10, 2002
Appl. No.:
10/269842
Inventors:
John Magnani - Gaithersburg MD, US
Eugene Butcher - Portola Valley CA, US
Ellen Berg - Palo Alto CA, US
Assignee:
John L. Magnani - Rockville MD
International Classification:
A61K038/17
A61K039/395
A61K031/739
US Classification:
424/155100, 514/008000, 514/054000
Abstract:
Methods and compositions are disclosed for the inhibition of cancer metastases mediated by endothelial adhesion molecules. The present invention discloses that sialyl Leand di-sialyl Le, which are expressed at the surface of cancer cells, function as a binding partner for LEC-CAMs, such as ELAM-1, which are expressed at the surface of endothelial cells. The present invention also discloses that LEC-CAMs, such as ELAM-1, involved in cancer metastasis share a carbohydrate domain common to both sialyl Leand sialyl Le. Antibodies, saccharides, glycoconjugates, enzyme inhibitors and other compounds may be used in the methods of the present invention to inhibit the binding of malignant cells to endothelial cells for a variety of purposes in vivo and in vitro.

Methods For The Inhibition Of Cancer Metastasis Mediated By Endothelial Adhesion Molecules

US Patent:
6121233, Sep 19, 2000
Filed:
May 5, 1994
Appl. No.:
8/238684
Inventors:
John L. Magnani - Rockville MD
Eugene C. Butcher - Portola Valley CA
Ellen L. Berg - Fremont CA
International Classification:
A61K 31715
US Classification:
514 8
Abstract:
Methods and compositions are disclosed for the inhibition of cancer metastases mediated by endothelial adhesion molecules. The present invention discloses that sialyl Le. sup. a and di-sialyl Le. sup. a, which are expressed at the surface of cancer cells, function as a binding partner for LEC-CAMs, such as ELAM-1, which are expressed at the surface of endothelial cells. The present invention also discloses that LEC-CAMs, such as ELAM-1, involved in cancer metastasis share a carbohydrate domain common to both sialyl Le. sup. a and sialyl Le. sup. x. Antibodies, saccharides, glycoconjugates, enzyme inhibitors and other compounds may be used in the methods of the present invention to inhibit the binding of malignant cells to endothelial cells for a variety of purposes in vivo and in vitro.

Possible Relatives

Cynthia L Berg  David S Berg  Cyrus R Berg  Dawn A Berg  Dean Berg  Dale D Berg  Debbie L Berg  Ellen M Johnson  Ellen M Johnston  Ellen V White 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.